Use of DHA in the form of phospholipids for the preparation of a composition for the treatment of respiratory failure

摘要

Use of at least one phospholipid of general formula (I) ** Formula ** in which at least one of the groups R1 or R2 represents a docosahexaenoyl (DHA) moiety, the other representing, if appropriate, a saturated acyl moiety or unsaturated comprising 8 to 24 carbon atoms, and the R3 group represents a choline, serine, ethanolamine, inositol, glycerol or hydrogen moiety, in the form of an egg enriched in DHA or in egg extracts enriched in DHA, for the preparation of an enteral composition intended for the treatment and / or prevention of respiratory failure in a patient, particularly a human being, at a dose of 200 mg / day of DHA.